Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maximilian Lennartz

Showing results (21-30 of 113) with videos related to

Pageof 12
Sort By:
Pathology, Research and Practice|November 9, 2024
PGP9.5 expression in human tumors: A tissue microarray study on 13,920 tumors from 120 different tumor entitiesSekander Scherzai, Maximilian Lennartz, Frank Jacobsen, et al.
Scientific Reports|July 15, 2025
MTAP deficiency is highly homogeneous in advanced, muscle-invasive urothelial carcinoma of the urinary bladderNatalia Gorbokon, Katharina Teljuk, Viktor Reiswich, et al.
Genes, Chromosomes & Cancer|January 24, 2026
PTEN Deletions Are Associated With Tumor Progression But Unrelated to Patient Prognosis in Muscle-Invasive Urothelial Bladder Carcinomas: A Large Multi-Center Validation Study on 2710 Urothelial Bladder CarcinomasMartina Kluth, Henning Plage, Kira Furlano, et al.
Diagnostics (Basel, Switzerland)|October 27, 2022
Analysis of More than 16,000 Human Tumor and Normal Tissues Identifies Uroplakin 3B as a Useful Diagnostic Marker for Mesothelioma and Normal Mesothelial CellsMaximilian Lennartz, Dennis Atug, Sebastian Dwertmann Rico, et al.
International Urology and Nephrology|April 2, 2021
Tumor cell PD-L1 expression is a strong predictor of unfavorable prognosis in immune checkpoint therapy-naive clear cell renal cell cancerKatharina Möller, Christoph Fraune, Niclas C Blessin, et al.
Virchows Archiv : an International Journal of Pathology|October 8, 2024
TTF-1 is a highly sensitive but not fully specific marker for pulmonary and thyroidal cancer: a tissue microarray study evaluating more than 17,000 tumors from 152 different tumor entitiesKatharina Möller, Tayyaba Gulzar, Maximilian Lennartz, et al.
Diagnostics (Basel, Switzerland)|December 24, 2021
Large-Scale Tissue Microarray Evaluation Corroborates High Specificity of High-Level Arginase-1 Immunostaining for Hepatocellular CarcinomaMaximilian Lennartz, Eva Gehrig, Sören Weidemann, et al.
International Urology and Nephrology|December 16, 2024
PLAP expression is linked to invasive tumor growth in urothelial carcinoma of the bladderHenning Plage, Kira Furlano, Sebastian Hofbauer, et al.
Annals of Diagnostic Pathology|August 27, 2022
Cytokeratin 10 (CK10) expression in cancer: A tissue microarray study on 11,021 tumorsRia Uhlig, Moussa Abboud, Natalia Gorbokon, et al.
The Journal of Pathology|January 19, 2023
Automated Ki-67 labeling index assessment in prostate cancer using artificial intelligence and multiplex fluorescence immunohistochemistryNiclas C Blessin, Cheng Yang, Tim Mandelkow, et al.
Pageof 12

Showing results (21-30 of 113) with videos related to

Sort By:
Pageof 12
Pathology, Research and Practice|November 9, 2024
PGP9.5 expression in human tumors: A tissue microarray study on 13,920 tumors from 120 different tumor entitiesSekander Scherzai, Maximilian Lennartz, Frank Jacobsen, et al.
Scientific Reports|July 15, 2025
MTAP deficiency is highly homogeneous in advanced, muscle-invasive urothelial carcinoma of the urinary bladderNatalia Gorbokon, Katharina Teljuk, Viktor Reiswich, et al.
Genes, Chromosomes & Cancer|January 24, 2026
PTEN Deletions Are Associated With Tumor Progression But Unrelated to Patient Prognosis in Muscle-Invasive Urothelial Bladder Carcinomas: A Large Multi-Center Validation Study on 2710 Urothelial Bladder CarcinomasMartina Kluth, Henning Plage, Kira Furlano, et al.
Diagnostics (Basel, Switzerland)|October 27, 2022
Analysis of More than 16,000 Human Tumor and Normal Tissues Identifies Uroplakin 3B as a Useful Diagnostic Marker for Mesothelioma and Normal Mesothelial CellsMaximilian Lennartz, Dennis Atug, Sebastian Dwertmann Rico, et al.
International Urology and Nephrology|April 2, 2021
Tumor cell PD-L1 expression is a strong predictor of unfavorable prognosis in immune checkpoint therapy-naive clear cell renal cell cancerKatharina Möller, Christoph Fraune, Niclas C Blessin, et al.
Virchows Archiv : an International Journal of Pathology|October 8, 2024
TTF-1 is a highly sensitive but not fully specific marker for pulmonary and thyroidal cancer: a tissue microarray study evaluating more than 17,000 tumors from 152 different tumor entitiesKatharina Möller, Tayyaba Gulzar, Maximilian Lennartz, et al.
Diagnostics (Basel, Switzerland)|December 24, 2021
Large-Scale Tissue Microarray Evaluation Corroborates High Specificity of High-Level Arginase-1 Immunostaining for Hepatocellular CarcinomaMaximilian Lennartz, Eva Gehrig, Sören Weidemann, et al.
International Urology and Nephrology|December 16, 2024
PLAP expression is linked to invasive tumor growth in urothelial carcinoma of the bladderHenning Plage, Kira Furlano, Sebastian Hofbauer, et al.
Annals of Diagnostic Pathology|August 27, 2022
Cytokeratin 10 (CK10) expression in cancer: A tissue microarray study on 11,021 tumorsRia Uhlig, Moussa Abboud, Natalia Gorbokon, et al.
The Journal of Pathology|January 19, 2023
Automated Ki-67 labeling index assessment in prostate cancer using artificial intelligence and multiplex fluorescence immunohistochemistryNiclas C Blessin, Cheng Yang, Tim Mandelkow, et al.
Pageof 12